We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M Turnover 17.39%
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+7.02%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$192M
AUM Growth
+$3.85M
Cap. Flow
-$2.08M
Cap. Flow %
-1.08%
Top 10 Hldgs %
60.53%
Holding
106
New
35
Increased
12
Reduced
5
Closed
35
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.7 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.8 years
Top 20 Avg Time Held Equity only
0.7 years

Sector Composition

Rank Sector Weight
1 Healthcare 63.02%
2 Miscellaneous 10.13%
3 Industrials 9.72%
4 Financials 7.48%
5 Consumer Discretionary 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CVS icon
1
CVS Health
CVS
$103B
$22.8M 11.84%
217,000
– –
2013 Q2
8 quarters
RRTS
2
DELISTED
Roadrunner Transportation Systems
RRTS
$18.4M 9.57%
28,533
+533
+2% +$341K
2013 Q2
8 quarters
CAH icon
3
Cardinal Health
CAH
$63.1B
$15.1M 7.83%
180,000
– –
2013 Q2
8 quarters
MCK icon
4
McKesson
MCK
$123B
$11.5M 6%
+51,300
New +$11.9M
2015 Q2
0 quarters
FOMX
5
DELISTED
Foamix Pharmaceuticals
FOMX
$10.1M 5.25%
984,734
+113,081
+13% +$1.25M
2014 Q3
3 quarters
ZVRA icon
6
Zevra Therapeutics
ZVRA
$521M
$10M 5.2%
+34,040
New +$7.42M
2015 Q2
0 quarters
PFNX
7
DELISTED
Pfenex
PFNX
$7.41M 3.85%
381,819
-178,181
-32% -$2.99M
2014 Q3
3 quarters
ELV icon
8
Elevance Health
ELV
$85.2B
$7.39M 3.84%
45,000
– –
2013 Q2
8 quarters
MFIC icon
9
MidCap Financial Investment
MFIC
$811M
$6.9M 3.59%
325,000
– –
2013 Q4
6 quarters
HCA icon
10
HCA Healthcare
HCA
$99.3B
$6.8M 3.54%
75,000
– –
2014 Q4
2 quarters
SCI icon
11
Service Corp International
SCI
$9.4B
$6.48M 3.37%
220,000
– –
2014 Q4
2 quarters
SPY icon
12
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$732B
$5.7M 2.97%
1,400,000
+350,000
+33% +$73.6M
2014 Q1
5 quarters
APO icon
13
Apollo Global Management
APO
$65.6B
$5.54M 2.88%
250,000
– –
2015 Q1
1 quarter
MRK icon
14
Merck
MRK
$330B
$3.64M 1.9%
67,072
– –
2013 Q2
8 quarters
ALKS icon
15
Alkermes
ALKS
$7.55B
$3.58M 1.86%
55,700
+10,700
+24% +$655K
2013 Q3
7 quarters
OPCH icon
16
Option Care Health
OPCH
$4.73B
$3.17M 1.65%
218,467
-81,533
-27% -$1.38M
2013 Q4
6 quarters
IVE icon
17
iShares S&P 500 Value ETF
IVE
$48.7B
$2.81M 1.46%
+30,496
New +$2.88M
2015 Q2
0 quarters
ACAD icon
18
Acadia Pharmaceuticals
ACAD
$2.96B
$2.72M 1.42%
65,000
– –
2015 Q1
1 quarter
IWD icon
19
iShares Russell 1000 Value ETF
IWD
$79.8B
$2.67M 1.39%
+25,920
New +$2.72M
2015 Q2
0 quarters
DVAX icon
20
DELISTED
Dynavax Technologies
DVAX
$2.34M 1.22%
+100,000
New +$2.18M
2015 Q2
0 quarters
CMRX icon
21
DELISTED
Chimerix
CMRX
$2.31M 1.2%
50,000
– –
2014 Q1
5 quarters
AMGN icon
22
Amgen
AMGN
$236B
$2.3M 1.2%
15,000
– –
2013 Q2
8 quarters
PAG icon
23
Penske Automotive Group
PAG
$13.9B
$2.22M 1.15%
+42,500
New +$2.2M
2015 Q2
0 quarters
C icon
24
Citigroup
C
$183B
$1.93M 1.01%
35,000
– –
2014 Q2
4 quarters
MSFT icon
25
Microsoft
MSFT
$3.6T
$1.84M 0.96%
41,695
+20,734
+99% +$946K
2014 Q2
4 quarters

Similar funds

DSC Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, DSC Advisors held 106 positions worth $192M, up 2% from $188M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

DSC Advisors's Q2 2015 filing shows 35 new, 12 increased, 5 reduced and 35 closed positions. Its largest new stake was McKesson: 51,300 shares worth $11.5M. The largest sale was Tapestry, an estimated $6.22M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 50% a quarter earlier, followed by Miscellaneous and Industrials.

  • DSC Advisors's largest Q2 2015 buy was McKesson: 51,300 shares worth $11.5M.
  • DSC Advisors added most to Foamix Pharmaceuticals in Q2 2015, an estimated $1.25M increase.
  • DSC Advisors's biggest Q2 2015 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.74M.
  • DSC Advisors fully exited Tapestry in Q2 2015, selling an estimated $6.22M.
  • DSC Advisors's ten largest holdings make up 61% of its $192M portfolio in Q2 2015.
  • DSC Advisors opened 35 new positions and closed 35 in Q2 2015.
  • DSC Advisors's portfolio value rose 2% quarter-over-quarter to $192M.

Based on DSC Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.